Australian Legislators Debate Whether To Ease Restrictions On Producing Generic Drugs For Export
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The Australian government is mulling whether to allow local manufacturers to produce generic versions of drugs that are still under patent protection inside the country for export to markets in which patents have expired
You may also be interested in...
An Unexpected Foe Challenges Pharma In Aussie Generics-For-Export Battle
Generic manufacturers and labor groups in Australia say current patent legislation is handicapping industry's ability to compete on the world stage and that, if the status quo remains, manufacturing and jobs are likely to go elsewhere
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).